# Actinium Pharmaceuticals, Inc.: Form 8-K, filed Dec 30, 2022

- Company: [Actinium Pharmaceuticals, Inc.](/companies/atnm.md) (CIK 1388320)
- Form: 8-K
- Filed: 2022-12-30
- Accepted by EDGAR: Dec 30, 2022, 22:00 ET
- Period: 2022-12-30
- Accession: 0001213900-22-084094
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1388320/000121390022084094/ea171085-8k_actinium.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1388320/000121390022084094/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1388320/000121390022084094/ea171085-8k_actinium.htm

Filed Dec 30, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-084094. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.